0001127602-24-014852.txt : 20240509
0001127602-24-014852.hdr.sgml : 20240509
20240509190201
ACCESSION NUMBER: 0001127602-24-014852
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240507
FILED AS OF DATE: 20240509
DATE AS OF CHANGE: 20240509
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gordon Murdo
CENTRAL INDEX KEY: 0001642156
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37702
FILM NUMBER: 24932409
MAIL ADDRESS:
STREET 1: C/O BRISTOL-MYERS SQUIBB COMPANY
STREET 2: 345 PARK AVE
CITY: NEW YORK
STATE: NY
ZIP: 10154
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 953540776
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER COMPANY:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
4
1
form4.xml
PRIMARY DOCUMENT
X0508
4
2024-05-07
0000318154
AMGEN INC
AMGN
0001642156
Gordon Murdo
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320
1
EVP, Global Commercial Ops
0
Common Stock
2024-05-07
4
A
0
3529
0
A
52674
D
Nqso (Right to Buy)
300.30
2024-05-07
4
A
0
22930
300.30
A
2026-05-07
2034-05-07
Common Stock
22930
45860
D
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 1,419 RSUs which will vest on 4/30/2025; 2,902 which will vest in installments of 1,429 on 5/2/2025, and 1,473 on 5/2/2026; 4,237 RSUs which will vest in two installments of 1,398 each on 5/2/2025 and 5/2/2026, and one installment of 1,441 on 5/2/2027; and 3,529 RSUs which will vest in installments of 1,164 on 5/7/2026, 1,165 on 5/7/2027, and 1,200 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
These shares include 490 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.
/s/ Murdo Gordon
2024-05-09